Houston, Texas (PRWEB) November 09, 2012
Lex Mundi has published a new Counterfeit Medicinal Products Global Practice Guide which includes jurisdictional overviews on counterfeit medicine laws in jurisdictions around the world.
The counterfeiting of medicinal products is a serious and complex problem that threatens the health and life of individuals and can result in treatment failure or even death. Additionally, trade in such products causes significant losses to manufacturers and distributors of genuine medicinal products and, moreover, profits from the sale of such products contribute to the development of a "black economy".
While the scale of this problem is difficult to assess, this guide offers current legal information on this important global issue.
Prepared by members of the Lex Mundi Life Sciences Practice Group, this guide is part of the Lex Mundi Global Practice Guide series all of which are available to the public on the Lex Mundi website at http://www.lexmundi.com/globalpracticeguides .
Lex Mundi, the world’s leading association of independent law firms, has more than 160 member firms around the world, representing approximately 21,000 lawyers. Lex Mundi provides members with a trusted network of top-tier law firms that share similar values and a similar focus on quality. Through Lex Mundi, members can access unparalleled legal resources that enable them to serve their clients’ needs worldwide and to continuously improve all aspects of their firms. Member firms are located throughout North America, Europe, Latin America and the Caribbean, Asia and the Pacific, the Middle East and Africa.
Through its nonprofit affiliate, the Lex Mundi Pro Bono Foundation, Lex Mundi member firms provide pro bono legal assistance to social entrepreneurs around the globe. For more information, please visit http://www.lexmundi.com and http://www.lexmundiprobono.org